TrialBritish journal of cancer2012

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group.

A du Bois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.